2026 data Public-data reference. official source

Drug/Toxicology Test

16 procedures in Drug/Toxicology Test. Medicare reimbursement averages $98.77 per service; billed charges average N/A. Source: CMS Medicare Physician & Other Practitioners 2023.

Drug screening and toxicology testing

16 procedures · Avg Medicare payment: $98.77

Code Procedure Medicare Billed
87186 Evaluation Of Antimicrobial Drug (antibiotic,... $8.47 $53.73
80307 Testing For Presence Of Drug, By Chemistry Analyzers $60.31 $217.78
80305 Testing For Presence Of Drug, Read By Direct... $12.17 $61.91
87184 Evaluation Of Antimicrobial Drug (antibiotic,... $7.32 $24.76
80299 Quantitation Of Therapeutic Drug $18.24 $90.85
87181 Evaluation Of Antimicrobial Drug (antibiotic,... $4.63 $15.34
83014 Administration Of Drug For Helicobacter Pylori $7.67 $47.22
87900 Infectious Agent Drug Susceptibility Analysis $126.36 $244.68
84228 Quinine (drug) Level $11.38 $48.00
87185 Detection Of Antimicrobial Drug (antibiotic,... $4.63 $30.33
80306 Testing For Presence Of Drug, Read By Instrument... $16.56 $89.60
87187 Evaluation Of Antimicrobial Drug (antibiotic,... $39.36 $61.38
81418 Genomic Sequence Analysis Panel Of At Least 6 Genes... $758.80 $3,433.69
87904 Analysis Test By Nucleic Acid For Hiv-1 Virus, Each... $24.97 $46.83
87188 Evaluation Of Antimicrobial Drug (antibiotic,... $6.51 $64.40
87903 Analysis Test By Nucleic Acid For Hiv-1 Virus, First... $473.00 $834.34

Reading Drug/Toxicology Test Pricing Data

The 16 procedure codes grouped under Drug/Toxicology Test share a common clinical taxonomy in the CMS Medicare Physician & Other Practitioners dataset. Across this category, the average Medicare payment is $98.77 — the figure Medicare actually reimburses providers for the allowed amount after geographic and specialty adjustments. Drug screening and toxicology testing Each CPT/HCPCS code in the table above carries its own fee schedule value determined by CMS's Resource-Based Relative Value Scale (RBRVS), which weights physician work, practice expense, and professional liability.

Billed charges — the "Billed" column — often run several multiples above Medicare allowed amounts. This is expected under US chargemaster pricing practices: providers list a gross rate, then accept negotiated write-offs from Medicare, Medicaid, and commercial insurers under participation agreements. A high markup ratio does not necessarily indicate overcharging, because almost no payer pays the full billed charge. However, uninsured and out-of-network patients can be exposed to amounts closer to the billed rate, which is why federal rules now require providers to publish cash and negotiated prices through the Hospital Price Transparency initiative.

Volume matters when interpreting category-level data. Procedures with millions of annual services — evaluation visits, common diagnostic work — reflect stable, well-benchmarked pricing. Lower-volume codes may show wider variation across providers and settings because small sample sizes produce less stable averages. When comparing specific procedures, drill into the individual procedure page for state-level breakdowns, provider counts, and commercial pricing estimates derived from RAND 2024 research. This page presents CMS reference data for educational use; it does not constitute medical, legal, or financial advice.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial  · Verify with CMS →

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from CMS (Centers for Medicare and Medicaid Services). Consult a qualified professional before making decisions based on this data.

Related Guides